» Articles » PMID: 39169604

Management of Bilateral Head and Neck Paragangliomas at a Single-institution Across Four Decades

Overview
Journal Head Neck
Date 2024 Aug 22
PMID 39169604
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bilateral head and neck paragangliomas (HNPGLs) require nuanced management to balance tumor control with functional preservation.

Methods: All patients seen at a single-institution for bilateral paraganglioma between 1983 and 2023 were retrospectively reviewed. Demographics, genetic testing results, and tumor characteristics were analyzed and compared to treatment modality and cranial nerve outcomes.

Results: There were 49 patients with 116 tumors (90 carotid body tumors [CBTs], 15 vagal paragangliomas [VPs], and 11 jugular paragangliomas [JPs]). Twenty-six patients had SDH pathologic variants (PV). Surgical management was more commonly utilized in younger patients (OR: 0.97, 95% CI: 0.950-0.992) and for JPs (OR: 9, 95% CI: 1.386-58.443). In surgical cases, CBTs had a lower risk of postoperative cranial nerve deficits compared to JPs and VPs (OR: 0.095, 95% CI: 0.013-0.692).

Conclusions: Younger patients with bilateral HNPGLs, especially those with JP and CBT, are more often treated with surgery. CBTs have lowest risk of cranial nerve deficits after surgery.

Citing Articles

Management of bilateral head and neck paragangliomas at a single-institution across four decades.

Bellamkonda N, Tooker E, Naumer A, Buchmann L, Kohlmann W, McCrary H Head Neck. 2024; 47(1):386-393.

PMID: 39169604 PMC: 11635744. DOI: 10.1002/hed.27923.

References
1.
Cleere E, Martin-Grace J, Gendre A, Sherlock M, ONeill J . Contemporary management of paragangliomas of the head and neck. Laryngoscope Investig Otolaryngol. 2022; 7(1):93-107. PMC: 8823187. DOI: 10.1002/lio2.706. View

2.
Taieb D, Kaliski A, Boedeker C, Martucci V, Fojo T, Adler Jr J . Current approaches and recent developments in the management of head and neck paragangliomas. Endocr Rev. 2014; 35(5):795-819. PMC: 4167435. DOI: 10.1210/er.2014-1026. View

3.
Drovdlic C, Myers E, Peters J, Baysal B, Brackmann D, Slattery 3rd W . Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope. 2002; 111(10):1822-7. DOI: 10.1097/00005537-200110000-00029. View

4.
Remacha L, Curras-Freixes M, Torres-Ruiz R, Schiavi F, Torres-Perez R, Calsina B . Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genet Med. 2018; 20(12):1644-1651. DOI: 10.1038/s41436-018-0003-y. View

5.
Dahia P . Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014; 14(2):108-19. DOI: 10.1038/nrc3648. View